Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Isabelle, Mussot"'
Autor:
Sandie Balcaen, Ibrahim Yakoub-Agha, Anne Wallart, John De Vos, Jérôme Mouchebeuf, Eva Lemarchand, Tamim Alsuliman, Carole Genty, Sarah Bole, Isabelle Mussot, Yohann Desbrosses, Laure Tardieu, Sophie Porcheron, Sylvie Tarillon, Jean El Cheikh, Marie Agnès Guerout-Verite, Sandrine Godin, Christelle Andrianne
Publikováno v:
Bulletin du Cancer. 106:S83-S91
JACIE (Joint Accreditation Committee ISTC EBMT) regulations and standards impose a quality and safety requirement for graft reinjection by nurses. However, the standards do not provide a step-by-step graft reinjection procedure. Because of high medic
Autor:
Ibrahim Yakoub-Agha, Anne Wallart Brejaud, Isabelle Fournier, Christelle Andrianne, Corinne Courbon, Josiane Delorme, Sarah Bole, Clotilde Aubrun, Maxime Berquier, Damien Lacroix, Ghislaine François, David Beauvais, Marlene Vercasson, Marie-France Jaivenois, Isabelle Mussot, Alexis Caulier, Laetitia Le Bars
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
International audience; In Europe, two CAR T-cell products, tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™), were approved in 2018. While these treatments are available for use, allogeneic hematopoietic stem cell transplantati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03db488bc89c986082e1ae6c920d6813
https://hal.archives-ouvertes.fr/hal-03492618
https://hal.archives-ouvertes.fr/hal-03492618
Autor:
David, Beauvais, Christelle, Andrianne, Clotilde, Aubrun, Maxime, Berquier, Sarah, Bole, Alexis, Caulier, Corinne, Courbon, Josiane, Delorme, Isabelle, Fournier, Ghislaine, François, Marie-France, Jaivenois, Laëtitia, Le Bars, Isabelle, Mussot, Marlène, Vercasson, Anne, Wallart Brejaud, Ibrahim, Yakoub-Agha, Damien, Lacroix
Publikováno v:
Bulletin du cancer. 107(12S)
In Europe, two CAR T-cell products, tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™), were approved in 2018. While these treatments are available for use, allogeneic hematopoietic stem cell transplantation centers still need to